Latest Transformation News

Phoslock Environmental Technologies has reversed its cashflow deficits with a quarterly surplus, resumed factory operations after a long pause, and is gearing up for significant sales growth in 2026.

Iondrive Limited appoints Lewis Utting as CEO to spearhead the transition from technology development to commercial execution of its IONSolv™ platform, while refreshing its board with new expertise.

Knosys’ Greenorbit subsidiary has inked a two-year agency deal with UK-based Oak Engage to offer its advanced intranet platform to existing Greenorbit customers, marking a strategic shift in Knosys’ product focus.

Epiminder Limited has achieved a major milestone with the first US implant of its Minder System at the University of Pennsylvania, kicking off a pivotal trial that could redefine epilepsy monitoring.

Tetratherix has inked a global exclusive distribution agreement with healthcare giant Henry Schein, paving the way for its first bone regeneration product, Tegenix, to enter major markets in 2026. Concurrently, the company has begun building an advanced manufacturing facility to meet expected global demand.

Podium Minerals has made significant strides at its Parks Reef PGM Project, launching a game-changing concentrator flowsheet and progressing a multi-phase drilling campaign, all supported by a successful A$12 million capital raise amid soaring platinum group metal prices.

Tungsten Mining NL has released an updated financial analysis for its Mt Mulgine project, illustrating a substantial uplift in project economics driven by record-high tungsten and precious metal spot prices. While the study remains illustrative, it highlights the potential for accelerated development amid a robust commodity market.

Truscott Mining has secured a drilling contract to kick off a 2,500-metre RC drilling program at its Westminster Project, alongside appointing a seasoned project geology manager to steer development efforts.

Osteopore Limited has inked an exclusive collaboration with Majeton to commercialise its cutting-edge 3D-printed bioresorbable implants across China, Hong Kong, and Macau, unlocking significant growth potential in the region.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Forrestania Resources has agreed to acquire key gold tenements from Gibraltar, consolidating its Coolgardie Hub footprint with a $2.5 million share deal plus contingent payments tied to resource discoveries.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.